These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 19714490)
1. p53 Tetramerization domain mutations: germline R342X and R342P, and somatic R337G identified in pediatric patients with Li-Fraumeni syndrome and a child with adrenocortical carcinoma. Fiszer-Maliszewska L; Kazanowska B; Padzik J; Fam Cancer; 2009; 8(4):541-6. PubMed ID: 19714490 [TBL] [Abstract][Full Text] [Related]
2. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil. Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735 [TBL] [Abstract][Full Text] [Related]
3. Report of 2 Pediatric Cases With Li-Fraumeni Syndrome Related Malignancy in a Family. Takeoka M; Toyoda H; Hirayama J; Suzuki N; Hanaki R; Amano K; Iwamoto S; Hirayama M J Pediatr Hematol Oncol; 2021 May; 43(4):e567-e570. PubMed ID: 32555031 [TBL] [Abstract][Full Text] [Related]
4. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes. Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481 [TBL] [Abstract][Full Text] [Related]
5. Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome. Lin MT; Shieh JJ; Chang JH; Chang SW; Chen TC; Hsu WH Pediatr Blood Cancer; 2009 Apr; 52(4):541-4. PubMed ID: 19101993 [TBL] [Abstract][Full Text] [Related]
6. TP53 germline mutations in adult patients with adrenocortical carcinoma. Herrmann LJ; Heinze B; Fassnacht M; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S J Clin Endocrinol Metab; 2012 Mar; 97(3):E476-85. PubMed ID: 22170717 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous Adrenocortical Carcinoma and Neuroblastoma in an Infant With a Novel Germline p53 Mutation. Courtney R; Ranganathan S J Pediatr Hematol Oncol; 2015 Apr; 37(3):215-8. PubMed ID: 25374282 [TBL] [Abstract][Full Text] [Related]
8. Towards an understanding of the role of p53 in adrenocortical carcinogenesis. Wasserman JD; Zambetti GP; Malkin D Mol Cell Endocrinol; 2012 Mar; 351(1):101-10. PubMed ID: 21930187 [TBL] [Abstract][Full Text] [Related]
9. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma. Sameshima Y; Tsunematsu Y; Watanabe S; Tsukamoto T; Kawa-ha K; Hirata Y; Mizoguchi H; Sugimura T; Terada M; Yokota J J Natl Cancer Inst; 1992 May; 84(9):703-7. PubMed ID: 1569604 [TBL] [Abstract][Full Text] [Related]
10. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation. Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190 [TBL] [Abstract][Full Text] [Related]
11. Two TP53 germline mutations in a classical Li-Fraumeni syndrome family. van Hest LP; Ruijs MW; Wagner A; van der Meer CA; Verhoef S; van't Veer LJ; Meijers-Heijboer H Fam Cancer; 2007; 6(3):311-6. PubMed ID: 17318340 [TBL] [Abstract][Full Text] [Related]
12. Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma. Grayson GH; Moore S; Schneider BG; Saldivar V; Hensel CH Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):341-7. PubMed ID: 7978053 [TBL] [Abstract][Full Text] [Related]
13. Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations. Choong SS; Latiff ZA; Mohamed M; Lim LL; Chen KS; Vengidasan L; Razali H; Abdul Rahman EJ; Ariffin H; Clin Genet; 2012 Dec; 82(6):564-8. PubMed ID: 22233476 [TBL] [Abstract][Full Text] [Related]
14. A novel p.Gly187Arg TP53 variant appears to result in Li-Fraumeni syndrome. Doyle MR; Johnston JM Pediatr Hematol Oncol; 2018 Apr; 35(3):203-207. PubMed ID: 30239254 [TBL] [Abstract][Full Text] [Related]
15. Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li-Fraumeni syndrome. Etzold A; Schröder JC; Bartsch O; Zechner U; Galetzka D Fam Cancer; 2015 Mar; 14(1):161-5. PubMed ID: 25226867 [TBL] [Abstract][Full Text] [Related]
16. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family. Kappel S; Janschek E; Wolf B; Rudas M; Teleky B; Jakesz R; Kandioler D Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898 [TBL] [Abstract][Full Text] [Related]
17. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers. Macedo GS; Vieira IA; Vianna FSL; Alemar B; Giacomazzi J; Brandalize APC; Caleffi M; Volc SM; de Campos Reis Galvão H; Palmero EI; Achatz MI; Ashton-Prolla P Fam Cancer; 2018 Apr; 17(2):269-274. PubMed ID: 28756477 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey. Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678 [TBL] [Abstract][Full Text] [Related]